We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.06B
AUM Growth
-$216M
Cap. Flow
-$186M
Cap. Flow %
-4.57%
Top 10 Hldgs %
19.83%
Holding
736
New
89
Increased
195
Reduced
242
Closed
87

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$35.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$26.2M
3
LLL
L3 Technologies, Inc.
LLL
+$25M
4
CLX icon
Clorox
CLX
+$21.2M
5
V icon
Visa
V
+$21M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$47.9M
2
AMZN icon
Amazon
AMZN
+$31M
3
AGN
Allergan plc
AGN
+$26.5M
4
CTSH icon
Cognizant
CTSH
+$22.3M
5
UAL icon
United Airlines
UAL
+$20.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.26%
2 Technology 13.82%
3 Financials 10.83%
4 Communication Services 10.67%
5 Consumer Staples 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGK icon
526
Vanguard FTSE Europe ETF
VGK
$30B
$266K 0.01%
+5,491
New +$257K
BSCH
527
DELISTED
Guggenheim BulletShares 2017 Corporate Bond ETF
BSCH
$265K 0.01%
+11,720
New +$265K
MKTX icon
528
MarketAxess Holdings
MKTX
$4.15B
$261K 0.01%
2,090
-3,405
-62% -$389K
RCL icon
529
Royal Caribbean
RCL
$78.7B
$256K 0.01%
3,120
-35,246
-92% -$2.75M
TUP
530
DELISTED
Tupperware Brands Corporation
TUP
$255K 0.01%
4,400
-850
-16% -$43.8K
CA
531
DELISTED
CA, Inc.
CA
$254K 0.01%
8,240
-1,394
-14% -$40K
HZNP
532
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$253K 0.01%
15,265
ORI icon
533
Old Republic International
ORI
$10.3B
$250K 0.01%
13,650
-1,000
-7% -$18K
GPC icon
534
Genuine Parts
GPC
$17.1B
$246K 0.01%
2,475
IBDM
535
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$244K 0.01%
+9,763
New +$239K
MMP
536
DELISTED
Magellan Midstream Partners, L.P.
MMP
$241K 0.01%
+3,500
New +$229K
RIO icon
537
Rio Tinto
RIO
$148B
$240K 0.01%
8,490
D icon
538
Dominion Energy
D
$62.5B
$237K 0.01%
3,158
-100
-3% -$7.08K
PICB icon
539
Invesco International Corporate Bond ETF
PICB
$351M
$237K 0.01%
+9,000
New +$227K
DVAX
540
DELISTED
Dynavax Technologies
DVAX
$234K 0.01%
12,175
WELL icon
541
Welltower
WELL
$178B
$234K 0.01%
3,369
+200
+6% +$12.9K
PNW icon
542
Pinnacle West Capital
PNW
$12.9B
$233K 0.01%
3,103
FITB
543
Fifth Third Bancorp
FITB
$52B
$231K 0.01%
13,850
CMI icon
544
Cummins
CMI
$91.7B
$227K 0.01%
+2,065
New +$200K
GL icon
545
Globe Life
GL
$13.5B
$223K 0.01%
4,125
AEP icon
546
American Electric Power
AEP
$73.7B
$211K 0.01%
3,185
-309
-9% -$19.1K
DEO icon
547
Diageo
DEO
$46.2B
$209K 0.01%
1,938
-21
-1% -$2.22K
LVS icon
548
Las Vegas Sands
LVS
$30.5B
$209K 0.01%
+4,045
New +$185K
ECON icon
549
Columbia Emerging Markets Consumer ETF
ECON
$327M
$208K 0.01%
+9,189
New +$188K
DFS
550
DELISTED
Discover Financial Services
DFS
$205K 0.01%
4,025
-1,100
-21% -$53K

Similar funds

Boston Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Boston Advisors held 736 positions worth $4.06B, down 5.1% from $4.28B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Advisors withdrew a net $186M in Q1 2016, closing 87 positions and reducing 242 holdings. Its most notable exit was DYAX CORPORATION, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Boston Advisors opened a new position in Baxter International worth $16.4M.

  • Boston Advisors's largest Q1 2016 buy was Baxter International: 399,091 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q1 2016, an estimated $35.7M increase.
  • Boston Advisors's biggest Q1 2016 reduction was Mastercard, cutting an estimated $47.9M.
  • Boston Advisors fully exited DYAX CORPORATION in Q1 2016, selling an estimated $16.2M.
  • Boston Advisors's ten largest holdings make up 20% of its $4.06B portfolio in Q1 2016.
  • Boston Advisors opened 89 new positions and closed 87 in Q1 2016.
  • Boston Advisors's portfolio value fell 5.1% quarter-over-quarter to $4.06B.

Based on Boston Advisors's 13F filing for Q1 2016, filed 20 Apr 2016.